PMC:7228307 / 46049-47030
Annnotations
LitCovid_Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 88-94 | https://glytoucan.org/Structures/Glycans/G82576YO | denotes | fucose |
T3 | 124-130 | https://glytoucan.org/Structures/Glycans/G82576YO | denotes | fucose |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
879 | 178-186 | Gene | denotes | FcγRIIIa | Gene:2214 |
880 | 191-199 | Gene | denotes | FcγRIIIb | Gene:2215 |
881 | 272-279 | Gene | denotes | FcγRIIb | Gene:2213 |
882 | 377-385 | Gene | denotes | FcγRIIIa | Gene:2214 |
883 | 482-486 | Gene | denotes | HER2 | Gene:2064 |
884 | 493-497 | Gene | denotes | EGFR | Gene:1956 |
885 | 639-646 | Gene | denotes | FcγRIII | Gene:2214 |
886 | 750-757 | Gene | denotes | FcγRIII | Gene:2214 |
887 | 894-902 | Gene | denotes | FcγRIIIa | Gene:2214 |
888 | 948-955 | Gene | denotes | FcγRIIa | Gene:2212 |
889 | 878-886 | Gene | denotes | FcγRIIIb | Gene:2215 |
890 | 20-35 | Chemical | denotes | N‐linked glycan | |
891 | 88-94 | Chemical | denotes | fucose | MESH:D005643 |
892 | 124-130 | Chemical | denotes | fucose | MESH:D005643 |
893 | 448-453 | Disease | denotes | tumor | MESH:D009369 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T376 | 88-94 | Body_part | denotes | fucose | http://purl.org/sig/ont/fma/fma82790 |
T377 | 98-108 | Body_part | denotes | Antibodies | http://purl.org/sig/ont/fma/fma62871 |
T378 | 124-130 | Body_part | denotes | fucose | http://purl.org/sig/ont/fma/fma82790 |
T379 | 802-809 | Body_part | denotes | NK cell | http://purl.org/sig/ont/fma/fma63147 |
T380 | 805-809 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T381 | 837-847 | Body_part | denotes | neutrophil | http://purl.org/sig/ont/fma/fma62860 |
T382 | 923-933 | Body_part | denotes | neutrophil | http://purl.org/sig/ont/fma/fma62860 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T79 | 448-453 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
T80 | 819-823 | Disease | denotes | ADCC | http://purl.obolibrary.org/obo/MONDO_0008734 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T803 | 81-82 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T804 | 178-180 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T805 | 191-193 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T806 | 272-274 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T807 | 377-379 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T808 | 585-586 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T809 | 639-641 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T810 | 750-752 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T811 | 802-809 | http://purl.obolibrary.org/obo/CL_0000623 | denotes | NK cell |
T812 | 878-880 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T813 | 894-896 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T814 | 948-950 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T235 | 88-94 | Chemical | denotes | fucose | http://purl.obolibrary.org/obo/CHEBI_33984 |
T236 | 124-130 | Chemical | denotes | fucose | http://purl.obolibrary.org/obo/CHEBI_33984 |
T237 | 766-774 | Chemical | denotes | effector | http://purl.obolibrary.org/obo/CHEBI_35224 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T221 | 805-809 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cell |
T222 | 934-943 | http://purl.obolibrary.org/obo/BFO_0000034 | denotes | functions |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T48 | 88-94 | Chemical | denotes | fucose | http://purl.obolibrary.org/obo/CHEBI_33984 |
T49 | 124-130 | Chemical | denotes | fucose | http://purl.obolibrary.org/obo/CHEBI_33984 |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
879 | 178-186 | Gene | denotes | FcγRIIIa | Gene:2214 |
880 | 191-199 | Gene | denotes | FcγRIIIb | Gene:2215 |
881 | 272-279 | Gene | denotes | FcγRIIb | Gene:2213 |
882 | 377-385 | Gene | denotes | FcγRIIIa | Gene:2214 |
883 | 482-486 | Gene | denotes | HER2 | Gene:2064 |
884 | 493-497 | Gene | denotes | EGFR | Gene:1956 |
885 | 639-646 | Gene | denotes | FcγRIII | Gene:2214 |
886 | 750-757 | Gene | denotes | FcγRIII | Gene:2214 |
887 | 894-902 | Gene | denotes | FcγRIIIa | Gene:2214 |
888 | 948-955 | Gene | denotes | FcγRIIa | Gene:2212 |
889 | 878-886 | Gene | denotes | FcγRIIIb | Gene:2215 |
890 | 20-35 | Chemical | denotes | N‐linked glycan | |
891 | 88-94 | Chemical | denotes | fucose | MESH:D005643 |
892 | 124-130 | Chemical | denotes | fucose | MESH:D005643 |
893 | 448-453 | Disease | denotes | tumor | MESH:D009369 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T269 | 0-280 | Sentence | denotes | The typical complex N‐linked glycan attached to N297 of the heavy chain includes a core fucose.85 Antibodies that lack this fucose have approximately 50‐fold improved binding to FcγRIIIa and FcγRIIIb and importantly retain the weak, low‐affinity binding to the inhibitory FcγRIIb. |
T270 | 281-655 | Sentence | denotes | Furthermore, this glycoengineering increased binding affinity of the modified IgG1 mAb for both FcγRIIIa V158 and F158 allelotypes.86, 87, 88 Afucosyl versions of the tumor targeting mAbs such as anti‐HER2, anti‐EGFR and anti‐CD20 had greater antitumor effects and increased survival,68, 88, 89 which is a reflection of the greatly increased, and selective, FcγRIII binding. |
T271 | 656-981 | Sentence | denotes | Compared with their unmodified counterparts, the afucosyl mAbs showed dramatic improvement of FcγRIII‐related effector responses such as stronger NK cell‐mediated ADCC, or enhanced neutrophil‐mediated phagocytosis through FcγRIIIb and/or FcγRIIIa.23 However, certain neutrophil functions via FcγRIIa may be compromised.90, 91 |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T582 | 507-511 | Protein | denotes | CD20 | https://www.uniprot.org/uniprot/Q3C2E2|https://www.uniprot.org/uniprot/Q13963|https://www.uniprot.org/uniprot/P19437|https://www.uniprot.org/uniprot/P11836|https://www.uniprot.org/uniprot/P08984|https://www.uniprot.org/uniprot/B4DT24|https://www.uniprot.org/uniprot/A6NMS4 |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T375 | 88-94 | Body_part | denotes | fucose | http://purl.org/sig/ont/fma/fma82790 |
T376 | 98-108 | Body_part | denotes | Antibodies | http://purl.org/sig/ont/fma/fma62871 |
T377 | 124-130 | Body_part | denotes | fucose | http://purl.org/sig/ont/fma/fma82790 |
T378 | 802-809 | Body_part | denotes | NK cell | http://purl.org/sig/ont/fma/fma63147 |
T379 | 805-809 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T380 | 837-847 | Body_part | denotes | neutrophil | http://purl.org/sig/ont/fma/fma62860 |
T381 | 923-933 | Body_part | denotes | neutrophil | http://purl.org/sig/ont/fma/fma62860 |
LitCovid-sample-PD-GO-BP-0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T107 | 493-497 | http://purl.obolibrary.org/obo/GO_0005006 | denotes | EGFR |
T108 | 819-823 | http://purl.obolibrary.org/obo/GO_0001788 | denotes | ADCC |
T109 | 857-869 | http://purl.obolibrary.org/obo/GO_0006909 | denotes | phagocytosis |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T35 | 448-453 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
LitCovid-sample-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T31 | 448-453 | Phenotype | denotes | tumor | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sample-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T107 | 493-497 | http://purl.obolibrary.org/obo/GO_0005006 | denotes | EGFR |
T108 | 819-823 | http://purl.obolibrary.org/obo/GO_0001788 | denotes | ADCC |
T109 | 857-869 | http://purl.obolibrary.org/obo/GO_0006909 | denotes | phagocytosis |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T107 | 493-497 | http://purl.obolibrary.org/obo/GO_0005006 | denotes | EGFR |
T108 | 819-823 | http://purl.obolibrary.org/obo/GO_0001788 | denotes | ADCC |
T109 | 857-869 | http://purl.obolibrary.org/obo/GO_0006909 | denotes | phagocytosis |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T269 | 0-280 | Sentence | denotes | The typical complex N‐linked glycan attached to N297 of the heavy chain includes a core fucose.85 Antibodies that lack this fucose have approximately 50‐fold improved binding to FcγRIIIa and FcγRIIIb and importantly retain the weak, low‐affinity binding to the inhibitory FcγRIIb. |
T270 | 281-655 | Sentence | denotes | Furthermore, this glycoengineering increased binding affinity of the modified IgG1 mAb for both FcγRIIIa V158 and F158 allelotypes.86, 87, 88 Afucosyl versions of the tumor targeting mAbs such as anti‐HER2, anti‐EGFR and anti‐CD20 had greater antitumor effects and increased survival,68, 88, 89 which is a reflection of the greatly increased, and selective, FcγRIII binding. |
T271 | 656-981 | Sentence | denotes | Compared with their unmodified counterparts, the afucosyl mAbs showed dramatic improvement of FcγRIII‐related effector responses such as stronger NK cell‐mediated ADCC, or enhanced neutrophil‐mediated phagocytosis through FcγRIIIb and/or FcγRIIIa.23 However, certain neutrophil functions via FcγRIIa may be compromised.90, 91 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T31 | 448-453 | Phenotype | denotes | tumor | http://purl.obolibrary.org/obo/HP_0002664 |